C12N 2502/02
Embryonic cells
Official title: embryonic cells
C12N2502/02 (Embryonic cells) appears on 187 US grants and 369 published applications in this corpus.
Search patents in C12N- Granted patents
- 187
- Published applications
- 369
- Assignees
- 166
- Inventors
- 508
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 4 |
| 2003 | 0 | 3 |
| 2004 | 2 | 4 |
| 2005 | 0 | 15 |
| 2006 | 1 | 17 |
| 2007 | 0 | 20 |
| 2008 | 5 | 14 |
| 2009 | 4 | 12 |
| 2010 | 7 | 20 |
| 2011 | 5 | 19 |
| 2012 | 9 | 21 |
| 2013 | 8 | 17 |
| 2014 | 25 | 23 |
| 2015 | 15 | 23 |
| 2016 | 16 | 15 |
| 2017 | 12 | 22 |
| 2018 | 5 | 12 |
| 2019 | 15 | 10 |
| 2020 | 10 | 20 |
| 2021 | 8 | 12 |
| 2022 | 5 | 18 |
| 2023 | 10 | 16 |
| 2024 | 6 | 12 |
| 2025 | 7 | 7 |
| 2026 | 6 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Artificial placenta and methods of preparation14 Jul 2026US 12,680,065 B2The Trustees of the University of Pennsylvania
- Methods for treating an immune disorder-related disease by reducing autoreactivity in a T cell compartment9 Jun 2026US 12,649,905 B2Hackensack University Medical Center
- Methods, culture medias and devices for generating embryos in vitro from stem cells5 May 2026US 12,618,830 B2California Institute of Technology
- Mitochondria-enriched genetically engineered cells and uses thereof21 Apr 2026US 12,605,410 B2Minovia Therapeutics Ltd.
- Cell population comprising mesenchymal cells, pharmaceutical composition comprising the same, and method for producing the same3 Mar 2026US 12,564,607 B2Kaneka Corporation
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells6 Aug 2026US 2026/0226415 A1IntegriCulture Inc.
- Methods, culture medias and devices for generating embryos in vitro from stem cells23 Jul 2026US 2026/0210944 A1California Institute of Technology
- Method for in vitro generation of human spermatids25 Jun 2026US 2026/0176579 A1Paterna Biosciences Inc.
- Immunocompatible chorionic membrane products28 May 2026US 2026/0144824 A1Osiris Therapeutics, Inc.
Most cited
By later US patents
- Treatment of retinitis pigmentosa with human umbilical cord cells175US 7,413,734 B2Ethicon, Inc. · 2008
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Methods for identifying factors for differentiating definitive endoderm163US 7,541,185 B2Cythera, Inc. · 2009
- Islet cells from human embryonic stem cells152US 7,033,831 B2Geron Corporation · 2006
- Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same84US 7,510,873 B2Ethicon, Inc. · 2009